Charles Schwab’s Applied Molecular Transport Inc. Common Stock AMTI Stock Holding History

Charles Schwab’s Portfolio AMTI Stock Details AMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-79,551	Closed	-$232K	–	3559
2022 Q2	$232K	Sell	79,551 -42,628	-35%	-$179K	﹤0.01%	3223
2022 Q1	$919K	Sell	122,179 -13,165	-10%	-$109K	﹤0.01%	2888
2021 Q4	$1.89M	Buy	135,344 +1,496	+1%	+$29.5K	﹤0.01%	2720
2021 Q3	$3.46M	Sell	133,848 -3,256	-2%	-$103K	﹤0.01%	2542
2021 Q2	$6.27M	Buy	137,104 +22,818	+20%	+$1.08M	﹤0.01%	2238
2021 Q1	$5.03M	Buy	114,286 +24,956	+28%	+$1.21M	﹤0.01%	2306
2020 Q4	$2.75M	Sell	89,330 -133	-0.1%	-$4.22K	﹤0.01%	2503
2020 Q3	$2.85M	Buy	+89,463	New	+$2.2M	﹤0.01%	2361

Other funds holding AMTI

ECG

EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return

FFVM

Founders Fund V Management San Francisco, California $2.16M AUM 77.37% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

FFVM

Founders Fund VI Management San Francisco, California $45.8K AUM 58.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Charles Schwab's AMTI Position: Q3 2022 in Review

Charles Schwab sold out of Applied Molecular Transport Inc. Common Stock (AMTI) in Q3 2022, closing a stake of 79,551 shares — an estimated $232K sold.

Charles Schwab first reported a position in AMTI in Q3 2020 and held it in 8 quarters. The position peaked at $6.27M in Q2 2021. 49 funds tracked by Wall St. Rank hold AMTI as of Q3 2022.

Charles Schwab reported no remaining Applied Molecular Transport Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Charles Schwab sold 79,551 Applied Molecular Transport Inc. Common Stock shares in Q3 2022, an estimated $232K.
Charles Schwab first reported a position in Applied Molecular Transport Inc. Common Stock in Q3 2020 and held it in 8 quarters.
Charles Schwab's Applied Molecular Transport Inc. Common Stock position peaked at $6.27M in Q2 2021.
49 funds tracked by Wall St. Rank held Applied Molecular Transport Inc. Common Stock as of Q3 2022.

Based on Charles Schwab's 13F filing for Q3 2022, filed 14 Nov 2022.